Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Folic acid to be used with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine

EU orphan designation number: EU/3/12/1044
Active ingredient: Folic acid to be used with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine
Indication: Diagnosis of positive folate receptor status in ovarian cancer
Sponsor: Endocyte Europe B.V.
Prins Bernhardplein 200, 1097 JB Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/09/2012 Orphan designation EMA/OD/056/12 (2012)6370 of 10/09/2012
30/11/2016 Removal of orphan designation from Community Register